DocWire News Editors

DocwireNews

<h2 class="entry-title"><a href="https://www.docwirenews.com/cardiology/bio-guardmi-higher-risk-non-st-elevation-myocardial-infarction-patients-might-benefit-from-implantable-cardiac-monitoring-and-early-arrhythmia-intervention/">BIO-GUARD|MI: Higher Risk Non-ST Elevation Myocardial Infarction Patients Might Benefit from Implantable Cardiac Monitoring and Early Arrhythmia Intervention</a><p>Implantable cardiac monitoring (ICM) to look for arrhythmias in post MI patients and prompt treatment did not provide clinical benefit, according to the results of the BIO-GUARD|MI trial. Interestingly though, ICM in higher risk Non-ST Elevation Myocardial Infarction (NSTEMI) patients appeared to have clinical benefits according to the study authors.</p><h2><a href="https://www.docwirenews.com/cardiology/discussing-the-valor-hcm-trial/">The VALOR-HCM Trial: Encouraging Findings for Patients with Obstructive HCM</a></h2><p>In this insightful interview,&nbsp;Rawan Amir, MBBS,&nbsp;and CardioNerds Academy Fellow, spoke with&nbsp;Milind Desai, MD, MBA,&nbsp;director of the Center for Hypertrophic Cardiomyopathy and medical director of the Center of Aortic Diseases, Cleveland Clinic, about the Phase III VALOR-HCM trial, which assessed mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy.</p><h2><a href="https://www.docwirenews.com/cardiology/dr-jessie-holtzman-discusses-the-cardionerds-medical-journalism-program/">Dr. Jessie Holtzman Discusses The CardioNerds Medical Journalism Program</a></h2><p><em>DocWire News</em>&nbsp;spoke to Dr. Jessie Holtzman, CardioNerds Executive Correspondent, about the CardioNerds Medical Journalism Program, an immersive program whereby CardioNerds Correspondents develop into seasoned journalists in the cardiovascular space. Dr. Holtzman talked about the importance of sound medical journalism, the significance of the program, and how the program supports the CardioNerds&rsquo; overarching mission of democratizing cardiovascular education.</p><h2><a href="https://www.docwirenews.com/cardionerds/keeping-scored-how-sotagliflozin-may-be-the-rising-star-of-sglt-inhibitors/">Keeping SCORED: How Sotagliflozin May Be the Rising Star of SGLT Inhibitors</a></h2><p>Empagliflozin has shown a reduction in all-cause and CV mortality and heart failure hospitalization rates in type-2 diabetes mellitus and a reduction in CV mortality and HF hospitalization rates with reduced or preserved EF. Canagliflozin has shown renal protection, reduction in death from MI and stroke, and lower HF rates in T2DM and chronic kidney disease. Dapagliflozin has shown lower rates of HF hospitalization and lower risk of worsening HF regardless of T2DM and in reduced EF, although the benefit in MACE reduction was unclear.</p></h2>


Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Cardiology Round-Up: Findings from the BIO-GUARD|MI, VALOR-HCM Trials; and More

Cardiology

BIO-GUARD|MI: Higher Risk Non-ST Elevation Myocardial Infarction Patients Might Benefit from Implantable Cardiac Monitoring and Early Arrhythmia Intervention ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe